Linkenheim, Germany

Bruno Brandalise


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Bruno Brandalise in Therapeutic Applications

Introduction

Bruno Brandalise is an accomplished inventor based in Linkenheim, Germany. He has made significant contributions to the field of medical technology, particularly in the preparation of radioisotopes for therapeutic use. His innovative work focuses on enhancing the efficacy of treatments through advanced methodologies.

Latest Patents

Bruno Brandalise holds a patent for a method and apparatus for preparing Bi-213 for human therapeutic use. This invention relates to a method and an apparatus designed to prepare Bi-213 to be integrated into a radioimmunoconjugate for human therapeutic applications. The method involves several key steps: first, an ampoule containing colloid-free actinium-225, obtained from drying an actinium nitrate solution, is loaded into a container equipped with radiation panels. Next, a dissolving medium is poured into the ampoule. The resulting solution is then transferred into an ion exchange column, where an elution medium is circulated through the column. Finally, the eluate containing eluted Bi-213 is pumped towards a vial for quantification and quality control. This innovative approach has the potential to significantly improve therapeutic outcomes.

Career Highlights

Bruno Brandalise has dedicated his career to advancing medical technologies. His work at the European Community has allowed him to collaborate with leading experts in the field. His innovative methods have garnered attention for their potential to enhance therapeutic applications in medicine.

Collaborations

Bruno has worked alongside notable colleagues such as Lothar Koch and Christos Apostolidis. Their combined expertise has contributed to the development of groundbreaking technologies in the medical field.

Conclusion

Bruno Brandalise's contributions to the preparation of Bi-213 for therapeutic use exemplify the impact of innovation in medicine. His work not only advances scientific knowledge but also holds promise for improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…